Related Experiment Video
Updated: Feb 22, 2026
Detection and Isolation of Cancer in Prostate Biopsies Using Stimulated Raman Histology and Artificial Intelligence
Published on: June 10, 2025
Raman spectroscopy for accurately characterizing biomolecular changes in androgen-independent prostate cancer cells
Stella Corsetti1, Thomas Rabl1,2, David McGloin1
1SUPA, School of Science and Engineering, University of Dundee, Dundee, Scotland.
Abstract:
Metastatic prostate cancer resistant to hormonal manipulation is considered the advanced stage of the disease and leads to most cancer-related mortality. With new research focusing on modulating cancer growth, it is essential to understand the biochemical changes in cells that can then be exploited for drug discovery and for improving responsiveness to treatment. Raman spectroscopy has a high chemical specificity and can be used to detect and quantify molecular changes at the cellular level. Collection of large data sets generated from biological samples can be employed to form discriminatory algorithms for detection of subtle and early changes in cancer cells. The present study describes Raman finger printing of normal and metastatic hormone-resistant prostate cancer cells including analyses with principal component analysis and linear discrimination. Amino acid-specific signals were identified, especially loss of arginine band. Androgen-resistant prostate cancer cells presented a higher content of phenylalanine, tyrosine, DNA and Amide III in comparison to PNT2 cells, which possessed greater amounts of L-arginine and had a B conformation of DNA. The analysis utilized in this study could reliably differentiate the 2 cell lines (sensitivity 95%; specificity 88%).
Insights
Raman spectroscopy identified distinct biochemical differences between normal and metastatic hormone-resistant prostate cancer cells, enabling accurate cell line differentiation. This technique aids in understanding cellular changes for improved cancer drug discovery.
Area of Science:
- Biochemistry
- Cell Biology
- Spectroscopy
Background:
- Metastatic prostate cancer resistant to hormonal manipulation represents an advanced disease stage with high mortality.
- Understanding biochemical alterations in cancer cells is crucial for developing targeted therapies and improving treatment response.
- Raman spectroscopy offers high chemical specificity for detecting molecular changes at the cellular level.
Purpose of the Study:
- To characterize the biochemical differences between normal and metastatic hormone-resistant prostate cancer cells using Raman spectroscopy.
- To develop discriminatory algorithms for early detection of subtle changes in cancer cells.
- To explore the potential of Raman fingerprinting for distinguishing between different prostate cancer cell lines.
Main Methods:
- Raman spectroscopy was employed for fingerprinting normal (PNT2) and metastatic hormone-resistant prostate cancer cells.
- Principal component analysis (PCA) and linear discriminant analysis (LDA) were utilized for data analysis.
- Identification and quantification of amino acid-specific signals and other biomolecules were performed.
Main Results:
- Specific amino acid signals were identified, notably a loss of the arginine band in resistant cells.
- Androgen-resistant cells showed increased phenylalanine, tyrosine, DNA, and Amide III content compared to PNT2 cells.
- PNT2 cells exhibited higher L-arginine levels and a B DNA conformation.
- The Raman spectroscopy analysis achieved high accuracy in differentiating the two cell lines (95% sensitivity, 88% specificity).
Conclusions:
- Raman spectroscopy effectively differentiates between normal and metastatic hormone-resistant prostate cancer cell lines based on their biochemical profiles.
- The identified biochemical markers, such as arginine levels and DNA conformation, are potential indicators of prostate cancer progression and resistance.
- This approach holds promise for label-free, high-throughput screening in cancer research and drug discovery.
